期刊文献+

替加环素治疗颅内耐药菌感染的研究进展 被引量:11

下载PDF
导出
摘要 目的:关注替加环素治疗颅内耐药菌感染的研究进展。方法:查阅近年来国内外相关文献,对替加环素治疗颅内耐药菌感染的9例病例进行归纳和分析。结果与结论:替加环素治疗颅内耐药菌感染多用于革兰阴性耐药菌感染,给药方式主要为静脉给药,维持剂量多为50 mg,bid,大多与其他抗菌药物联用。由于替加环素较大的表观分布容积和较差的血脑屏障透过能力,导致脑脊液中的药物浓度远低于治疗要求,从药理学上很难解释替加环素在合并用药方案中的有效性。提高替加环素在脑脊液中的药物浓度的给药方式有待进一步研究。
出处 《中国药房》 CAS 北大核心 2016年第14期2005-2008,共4页 China Pharmacy
基金 国家自然科学基金资助项目(No.81301118) 多肽及小分子药物北京市重点实验室开放课题计划(No.2014DTYW03) 首都医科大学学生科研创新项目(No.XSKY2015181)
  • 相关文献

参考文献24

  • 1Harms JM,Bartels H,Schlunzen F,et al.Antibiotics acting on the translational machinery[J].J Cell Sci,2003,116(8):1 391.
  • 2Hirata T,Nomura W,Imanishi M,et al.Effects of linking 15-zinc finger domains on DNA binding specificity and multiple DNA binding modes[J].Bioorg Med Chem Lett,2005,15(9):2 197.
  • 3FDA.Tygacil(tigecycline)for injection[EB/OL].(2013-09-30)[2015-04-05].http://www.fda.gov/Safety/MedW-atch/Safety Information/ucm228387.htm.
  • 4孙桂凤,陈頔,孙钊.新一代抗菌药物替加环素的研究进展[J].药品评价,2014,11(12):21-23. 被引量:27
  • 5常晓飞,何爱咏.某院骨科2006~2010年鲍曼不动杆菌耐药及治疗情况分析[J].中南药学,2012,10(2):154-157. 被引量:5
  • 6Bradford PA,Weaver-Sands DT,Petersen PJ.In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections[J].Clin Infect Dis,2005,41(5):S315.
  • 7Sader HS,Farrell DJ,Flamm RK,et al.Variation in potency and spectrum of tigecycline activity against bacterial strains from US medical centers since its approval for clinical use:2006-2012[J].Antimicrob Agents Ch,2014,58(4):2 274.
  • 8Gupta S,Aruna C,Nagaraj S,et al.In vitro activity of tigecycline against multidrug-resistant gram-negative blood culture isolates from critically ill patients[J].J Antimicrob Chemother,2012,67(5):1 293.
  • 9Babinchak T,Ellis-Grosse E,Dartois N,et al.The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections:analysis of pooled clinical trial data[J].Clin Infect Dis,2005,41(5):S354.
  • 10Ellis-Grosse EJ,Babinchak T,Dartois N,et al.The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections:results of 2 double-blind phase 3comparison studies with vancomycin-aztreonam[J].Clin Infect Dis,2005,41(5):S341.

二级参考文献46

  • 1陈佰义,何礼贤,胡必杰,等.中国鲍曼不动杆菌感染诊治与防控专家共识(2011)[J].中华医学杂志.http://wenku.baidu.com/view/lelbb021192e45361066f545.html,http://infect.dxy.cn/article/2011/12/31/17221.
  • 2Zhou H, Yang O, Yu Ys, et al. Clonal Spread of Imipenem resistant Acinetobacter baumannii among different cities of China [J]. Clin Microbiol, 2007, 45 (12): 4054-4057.
  • 3Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen [J]. Clin Microbiol Rev, 2008, 21(3): 538-582.
  • 4Mahgoub S, Ahmed J, Glatt AE. Underlying characteristics of patients harboring highly resistant Acinetobacter baumannii [J]. Am J Infect Corntrol, 2002, 30 (7): 386-390.
  • 5Galani I, Flora K, Maria S, et al. Colistin susceptibility tes ting by Etest and disk diffusion methods [J]. Int J Antimicrob Agents, 2008, 31 (5): 434-439.
  • 6Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobaeter baumannii and Pseudomonas aeruginosa [J]. J Med Microbiol, 2006, 55 (12): 1619-1629.
  • 7Paterson DL, Doi Y. A step closer to extreme drug resistance (XDR) in gram negative bacilli [J]. Clin Infect Dis, 2007, 45 (9): 1179-1181.
  • 8Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology [J]. Clin Infect Dis, 2008, 46 (7) : 1121-1122.
  • 9Catalano M, Quelle LS, Jeric PE, et al. Survival of Acineto-bacter baumannii on bed rails during an outbreak and during sporadic cases [J]. J Hosp Infect, 1999, 42 (1): 27-35.
  • 10陈佰义,何礼贤,胡必杰等.中国鲍曼不动杆菌感染诊治与防控专家共识(2011).中华医学杂志http://infect.dxy.cn/article/2011/12/31/17221,.

共引文献30

同被引文献85

引证文献11

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部